AbCellera Biologics Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Dec 2020 | $175.0M | $1.01B | $594.1M |
| Mar 2021 | $171.4M | $1.13B | $685.8M |
| Jun 2021 | $184.2M | $1.15B | $792.6M |
| Sep 2021 | $219.3M | $1.17B | $517.7M |
| Dec 2021 | $292.8M | $1.32B | $476.1M |
| Mar 2022 | $384.8M | $1.59B | $545.7M |
| Jun 2022 | $380.9M | $1.59B | $790.6M |
| Sep 2022 | $302.2M | $1.55B | $372.0M |
| Dec 2022 | $307.6M | $1.54B | $386.5M |
| Mar 2023 | $289.4M | $1.50B | $193.0M |
| Jun 2023 | $342.3M | $1.54B | $179.7M |
| Sep 2023 | $329.4M | $1.51B | $172.4M |
| Dec 2023 | $335.8M | $1.49B | $133.3M |
| Mar 2024 | $333.2M | $1.46B | $123.6M |
| Jun 2024 | $301.5M | $1.41B | $148.3M |
| Sep 2024 | $314.7M | $1.39B | $126.6M |
| Dec 2024 | $304.5M | $1.36B | $156.3M |
| Mar 2025 | $321.2M | $1.34B | $159.3M |
| Jun 2025 | $395.0M | $1.40B | $92.4M |
| Sep 2025 | $392.0M | $1.36B | $83.2M |
| Dec 2025 | $390.0M | $1.36B | $128.5M |
| Mar 2026 | $369.0M | $1.31B | $77.1M |
| Jun 2026 | $411.6M | $1.31B | $120.1M |